Patents Assigned to Alkaloid Ad
  • PHARMACEUTICAL FORMULATION
    Publication number: 20230172918
    Abstract: The present invention relates to a novel two-component formulation of an active ingredient, especially a proton pump inhibitor. The two component formulation is stable for extended periods on storage, and the components are combined to give a formulation that is suitable for oral administration, having good palatability and efficacy.
    Type: Application
    Filed: April 17, 2020
    Publication date: June 8, 2023
    Applicant: ALKALOID AD SKOPJE
    Inventors: Ljiljana KRSTESKA, Elena KAZANDZIEVSKA, Andrew WILLIS
  • Sublingual oral dosage form
    Patent number: 6572891
    Abstract: A pharmaceutical sublingual solid dosage form comprising a morphine salt together with excipients including a saccharide, a binder and a disintegrant. A method of manufacturing the dosage form is also described, together with packaging suitable for long term storage of the dosage form.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: June 3, 2003
    Assignee: Alkaloid Ad
    Inventor: Sonja Jovan Ugarkovic